August 27 | 2020
2cureX AB (”2cureX”) offentliggör härmed halvårsrapport för det första halvåret 2020
Read more
August 27 | 2020
2cureX AB (“2cureX”) hereby publishes the interim report for the first half of 2020.
Read more
August 4 | 2020
First day for trading in TO1 series warrants
Read more
August 4 | 2020
Första dag för handel med teckningsoptioner av serie TO1
Read more
July 13 | 2020
Avstämningsdag för tilldelning av teckningsoptioner av serie TO1 bestämd till den 17 juli 2020
Read more
July 13 | 2020
Record date for allotment of warrants of series TO1 is set to July 17, 2020
Read more
July 6 | 2020
2cureX completes a heavily oversubscribed directed issue of approximately SEK 40 million
Read more
July 6 | 2020
2cureX AB intends to carry out a directed issue of units
Read more
July 3 | 2020
2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner
Read more
July 3 | 2020
2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner
Read more
July 2 | 2020
Kommuniké från extra bolagsstämman i 2cureX AB (publ)
Read more
July 2 | 2020
Bulletin from the Extraordinary General Meeting in 2cureX AB (publ)
Read more
June 9 | 2020
Byte av Certified Adviser till Redeye AB
Read more
June 9 | 2020
Change of Certified Adviser to Redeye AB
Read more
May 28 | 2020
Communique from the Annual General Meeting in 2cureX AB (publ)
Read more
May 28 | 2020
Kommuniké från årsstämma i 2cureX AB (publ)
Read more
May 28 | 2020
2cureX offentliggör delårsrapport för det första kvartalet 2020
Read more
May 28 | 2020
2cureX publishes interim report for the first quarter of 2020
Read more